Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic varia...
Main Authors: | Sarah E. Podwika, Taylor M. Jenkins, Joyti K. Khokhar, Sarah H. Erickson, Susan C. Modesitt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920300357 |
Similar Items
-
SMARCA4 germline gene mutation in a patient with epithelial ovarian: A case report
by: Reshma Muppala, et al.
Published: (2017-11-01) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
by: Halide Nur URER, et al.
Published: (2023-05-01) -
A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
by: Ling Peng, et al.
Published: (2021-10-01) -
Thoracic SMARCA4-deficient undifferentiated tumor
by: Jiapeng Jiang, et al.
Published: (2023-04-01) -
Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
by: Andrew Berchuck, et al.
Published: (2015-04-01)